When gPTGS2 and IL1β levels were used to discriminate those CRC depending on IL1β for gPTGS2 expression (enriched in stromal gPTGS2) from tumors with an independent gPTGS2 expression (enriched in tumor gPTGS2), survival curves showed an immediate dichotomy. Here, IL1B is linked to neoplasm.